Mankind Pharma Ltd

Mankind Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Mankind Pharma Ltd

₹ 2,110 -0.87%
22 Jul 4:01 p.m.
mankindpharma.com BSE: 543904 NSE: MANKIND
About

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.[1]

Key Points

Leadership[1]

<h1>1 Rank in Prescriptions over the last 5 yrs.</h1> <h1>Youngest in Top 5 of the IPM</h1> <h1>4 By value in the IPM</h1> <h1>4 Consumer Healthcare brands Market ranked #1 in their categories</h1>
Website BSE NSE
  • Market Cap ₹ 84,550 Cr.
  • Current Price ₹ 2,110
  • High / Low ₹ 2,490 / 1,680
  • Stock P/E 46.8
  • Book Value ₹ 234
  • Dividend Yield 0.00 %
  • ROCE 26.2 %
  • ROE 21.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 9.03 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
1,726 2,180 2,426 2,091 2,053 2,579 2,708 2,607 2,441
1,441 1,724 1,835 1,654 1,636 1,924 2,025 2,000 1,850
Operating Profit 285 456 591 437 417 655 683 607 591
OPM % 16% 21% 24% 21% 20% 25% 25% 23% 24%
39 20 31 40 50 63 63 75 95
Interest 13 16 10 13 5 6 9 9 9
Depreciation 47 78 79 85 85 87 96 110 105
Profit before tax 263 382 533 379 377 624 641 562 572
Tax % 27% 22% 21% 22% 22% 21% 20% 18% 17%
193 298 423 296 294 494 511 460 477
EPS in Rs 4.75 7.30 10.48 7.09 7.13 12.15 12.51 11.33 11.76
Raw PDF
Upcoming result date: 31 July 2024

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3,334 5,865 6,214 7,782 8,749 10,335
2,748 4,427 4,565 5,791 6,848 7,796
Operating Profit 586 1,438 1,649 1,991 1,902 2,538
OPM % 18% 25% 27% 26% 22% 25%
76 122 183 210 141 294
Interest 2 23 21 60 46 35
Depreciation 39 99 119 167 326 398
Profit before tax 621 1,438 1,692 1,975 1,671 2,399
Tax % 29% 27% 24% 26% 22% 19%
445 1,056 1,293 1,453 1,310 1,942
EPS in Rs 219.33 25.72 31.59 35.78 32.00 47.75
Dividend Payout % 0% 0% 24% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 18%
TTM: 18%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 14%
TTM: 44%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 11%
Return on Equity
10 Years: %
5 Years: %
3 Years: 21%
Last Year: 22%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 20 40 40 40 40 40
Reserves 2,035 3,445 4,682 6,115 7,395 9,323
0 131 241 873 170 207
968 1,449 1,397 2,080 2,080 2,313
Total Liabilities 3,022 5,065 6,360 9,108 9,686 11,883
316 1,600 1,664 3,588 4,251 4,545
CWIP 47 317 372 701 550 282
Investments 959 829 1,512 1,109 1,346 2,568
1,700 2,319 2,811 3,709 3,538 4,488
Total Assets 3,022 5,065 6,360 9,108 9,686 11,883

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1,070 1,137 920 1,813 2,152
-436 -1,222 -1,369 -1,052 -2,081
-531 -8 605 -740 5
Net Cash Flow 103 -92 156 22 77

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 22 33 19 18 24 30
Inventory Days 166 175 243 265 188 179
Days Payable 71 145 137 162 126 127
Cash Conversion Cycle 117 63 125 121 86 82
Working Capital Days 56 35 43 62 45 41
ROCE % 37% 32% 22% 26%

Shareholding Pattern

Numbers in percentages

17 Recently
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
76.50% 76.50% 76.50% 74.88% 74.87%
4.18% 4.18% 6.74% 9.87% 11.58%
4.65% 4.56% 9.78% 11.14% 9.94%
14.67% 14.76% 6.97% 4.10% 3.61%
No. of Shareholders 1,31,9181,34,7311,27,4491,35,1161,53,450

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls